Different people develop disease and respond to treatments differently. Moving away from the one-size-fits-all approach, personalised medicine pursues treatment options tailored to the genetic profile ...
Researchers from FIMM, Karolinska Institutet and EMBL-EBI have joined forces to initiate a web-based platform, Drug Target Commons, which features tools for crowd-sourced bioactivity data annotation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results